Vicapsys Life Sciences, Inc. (VICP)

Vicapsys Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2009
Cash & Equivalents	0.01	0.22	0	0.26	0.12
Cash & Cash Equivalents	0.01	0.22	0	0.26	0.12
Cash Growth	-93.51%	17023.33%	-99.52%	116.58%	87.68%
Receivables	0	0	0	0	1.09
Inventory	0	0	0	0	0.6
Other Current Assets	0.06	0.01	0	0	0.06
Total Current Assets	0.07	0.22	0	0.26	1.87
Property, Plant & Equipment	0	0	0	0	0.35
Intangible Assets	0	0.37	0.4	0.43	0
Other Long-Term Assets	0.05	0	0	0	0.02
Total Long-Term Assets	0.05	0.37	0.4	0.43	0.36
Total Assets	0.07	0.59	0.4	0.7	2.23
Accounts Payable	0.91	0.6	0.74	0.4	0
Current Debt	0	0	0	0	1.43
Other Current Liabilities	0.12	0.12	0.12	0	2.22
Total Current Liabilities	1.02	0.72	0.85	0.4	3.65
Long-Term Debt	0	0	0	0	1.32
Other Long-Term Liabilities	0.91	0	0	0	0
Total Long-Term Liabilities	0.91	0	0	0	1.32
Total Liabilities	1.02	0.72	0.85	0.4	4.96
Total Debt	0	0	0	0	2.75
Debt Growth	-	-	-	-	118.28%
Common Stock	0.03	0.02	0.02	0.02	0.03
Retained Earnings	-15.12	-14.13	-13.89	-13.13	-5.91
Comprehensive Income	0	0.01	0	0	0
Shareholders' Equity	-0.95	-0.12	-0.45	0.3	-2.73
Total Liabilities and Equity	0.07	0.59	0.4	0.7	2.23
Net Cash / Debt	0.01	0.22	0	0.26	-2.63
Net Cash / Debt Growth	-93.51%	17023.33%	-99.52%	-	-
Net Cash Per Share	0.00	0.01	0.00	0.02	-7.58
Working Capital	-0.95	-0.49	-0.85	-0.13	-1.78
Book Value Per Share	-0.03	-0.01	-0.03	0.03	-7.88

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.